OQL011

· OnQuality Pharmaceuticals (USA) LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OQL011, covering 2024-03-04 to 2024-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients [Phase 2]